Mettler‑Toledo shares jump 25% as management raises 2026‑27 EPS guidance and pledges $875 million buyback
Mettler‑Toledo International (MTD) stock has risen about 25% in the past two months despite a slowdown in biotech venture funding. The company reported Q3 revenue of $1.09 billion and adjusted EPS of $12.57, and it lifted its full‑year 2026 EPS outlook to $47.70‑$47.90 and its early‑2027 outlook to $52.50‑$53.50. Management projects roughly $900 million of free cash flow this year, enough to fund an $875 million share‑repurchase program.
Why it matters
The company’s higher‑than‑consensus EPS guidance and sizable free‑cash‑flow‑backed buyback could sustain the share‑price rally, according to the management outlook. Analysts note that the upgraded guidance and buyback may further boost investor sentiment.
Key facts
- 1MTD stock has risen 25.2% over the past two months. investing.com
- 2Q3 revenue was $1.09 billion. investing.com
- 3Q3 adjusted EPS was $12.57. investing.com
- 4Full‑year 2026 EPS guidance is $47.70‑$47.90. investing.com
- 5Initial 2027 EPS guidance is $52.50‑$53.50. investing.com
- 6The company projects roughly $900 million of free cash flow this year. investing.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.